Tag: Roche
Roche: Green light from the FDA for the ‘cobas’ test
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Roche: green light from the FDA for the ‘cobas’ test
(CercleFinance.com) – Roche today announced the Food and Drug Administration (FDA) has approved the ‘cobas’ Malaria test for use on the cobas 6800/8800 systems. This test helps ensure that infected…
ROCHE BOBOIS: MONTHLY INFORMATION RELATING TO VOTING RIGHTS – 03/14/2024 at 6:00 p.m.
About ROCHE BOBOIS SA ROCHE BOBOIS SA is a French family business founded in 1960. The Group is present in 54 countries with a network of 340 stores (as of…
Roche: FDA approves treatment for allergies
(CercleFinance.com) – The group announces that the FDA has approved Xolair as the first and only drug intended for children and adults suffering from one or more food allergies. The…
Roche: new collaboration with PathAI in AI
(CercleFinance.com) – Roche announced on Tuesday that it would once again join forces with PathAI, a specialist in artificial intelligence applied to pathology, this time in the field of diagnosis…
ROCHE BOBOIS: THE MONTHLY LETTER – JANUARY 2024 – 02/12/2024 at 08:00
THE MONTHLY LETTER Roche Bobois, the international benchmark for high-end furniture and French Art of Living publishes its latest news every month. January 2024 IN THE FEATURES PRESS PRESENTATION IN…
Roche: UBS lowers its price target
(CercleFinance.com) – UBS confirms its neutral opinion on the stock and lowers its price target to 248 Swiss francs (instead of 262 Swiss francs) after the announcement of the results…
Roche: Stifel reduces its price target
(CercleFinance.com) – Stifel maintains its ‘hold’ rating on Roche shares, with a price target reduced from 306 to 280 Swiss francs. The broker reports that despite an expected increase in…
Roche Bobois: growth of 5% in annual turnover
(CercleFinance.com) – Roche Bobois announces a new turnover record for its 2023 financial year, up 5.1% (+6.1% at constant exchange rates) to 429.5 million euros, online therefore with its annual…
Roche Bobois: growth of 5% in annual turnover – 01/26/2024 at 2:15 p.m.
(CercleFinance.com) – Roche Bobois announces a new turnover record for its 2023 financial year, up 5.1% (+6.1% at constant exchange rates) to 429.5 million euros, online therefore with its annual…
Roche: End of licensing agreement with AC Immune
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Roche: licensing agreement with Remix Therapeutics
(CercleFinance.com) – Remix Therapeutics announced on Wednesday the conclusion of a collaboration and licensing agreement with Roche relating to the development of small therapeutic molecules targeting RNA. In a statement,…